Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 95

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Human pluripotent stem cell‐derived products: Advances towards robust, scalable and cost‐effective manufacturing strategies

Jenkins, Michael J., Farid, Suzanne S.·2015·Biotechnology Journal

Abstract

The ability to develop cost‐effective, scalable and robust bioprocesses for human pluripotent stem cells (hPSCs) will be key to their commercial success as cell therapies and tools for use in drug screening and disease modelling studies. This review outlines key process economic drivers for hPSCs and progress made on improving the economic and operational feasibility of hPSC bioprocesses. Factors influencing key cost metrics, namely capital investment and cost of goods, for hPSCs are discussed. Step efficiencies particularly for differentiation, media requirements and technology choice are amongst the key process economic drivers identified for hPSCs. Progress made to address these cost drivers in hPSC bioprocessing strategies is discussed. These include improving expansion and differentiation yields in planar and bioreactor technologies, the development of xeno‐free media and microcarrier coatings, identification of optimal bioprocess operating conditions to control cell fate and the development of directed differentiation protocols that reduce reliance on expensive morphogens such as growth factors and small molecules. These approaches offer methods to further optimise hPSC bioprocessing in terms of its commercial feasibility.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/biot.201400348

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 97

  1. 10.1016/j.cell.2006.07.024 · DOI · Paper page
  2. 10.1016/j.cell.2007.11.019 · DOI · Paper page
  3. 10.1038/nature10761 · DOI · Paper page
  4. 10.1038/nrd3000 · DOI · Paper page
  5. Grskovic M., 2011, Induced pluripotent stem cells –Opportunities for disease modelling and drug discovery., Nat. Rev. Drug Discov., 10, 915, 10.1038/nrd3577 · DOI · Paper page
  6. 10.1172/JCI40553 · DOI · Paper page
  7. 10.1038/ncb0511-497 · DOI · Paper page
  8. 10.1016/j.pharmthera.2012.01.005 · DOI
  9. 10.1002/bies.201200053 · DOI
  10. 10.1016/j.stem.2010.05.012 · DOI
  11. 10.2217/rme.12.40 · DOI
  12. 10.1089/scd.2012.0202 · DOI
  13. 10.1016/S0140-6736(12)60028-2 · DOI · Paper page
  14. 10.1371/journal.pone.0037004 · DOI · Paper page
  15. 10.1098/rsif.2008.0442 · DOI · Paper page
  16. 10.2217/17460751.4.2.153 · DOI
  17. 10.1002/bit.25008 · DOI · Paper page
  18. 10.1038/ncb2894 · DOI · Paper page
  19. 10.2217/rme.11.101 · DOI
  20. 10.1038/nrd2403 · DOI
  21. 10.1002/btpr.1825 · DOI
  22. 10.1016/j.tibtech.2012.03.003 · DOI · Paper page
  23. 10.1016/j.biotechadv.2013.08.009 · DOI
  24. 10.1016/j.biotechadv.2013.03.006 · DOI · Paper page
  25. 10.1002/stem.1260 · DOI · Paper page
  26. 10.1007/s10616-013-9687-7 · DOI
  27. 10.1089/ten.teb.2009.0270 · DOI · Paper page
  28. Lang H. J., 1948, Simplified approach to preliminary cost estimates., Chem. Eng., 55, 112
  29. 10.1002/bit.24608 · DOI · Paper page
  30. 10.1016/j.cherd.2013.08.021 · DOI
  31. 10.1002/bit.21673 · DOI
  32. 10.1021/bp049692b · DOI
  33. 10.1002/bit.20757 · DOI
  34. 10.1387/ijdb.082590le · DOI
  35. Rowley J., 2012, Meeting lot‐size challenges of manufacturing adherent cells for therapy., BioProcess Int., 10, 16
  36. 10.1016/j.biotechadv.2011.06.009 · DOI · Paper page
  37. Brandenburger R., 2011, Cell therapy bioprocessing., BioProcess Int., 9, 30
  38. 10.1002/bit.22187 · DOI · Paper page
  39. 10.1016/j.scr.2009.02.005 · DOI · Paper page
  40. 10.1002/bit.20045 · DOI · Paper page
  41. 10.1089/ten.tec.2011.0717 · DOI · Paper page
  42. 10.1080/20013891081692 · DOI · Paper page
  43. 10.1089/ten.tec.2010.0320 · DOI
  44. 10.1038/nmeth.1593 · DOI · Paper page
  45. 10.1016/j.scr.2013.07.011 · DOI
  46. 10.1089/ten.tec.2012.0141 · DOI
  47. 10.1016/j.jbiotec.2008.07.1997 · DOI · Paper page
  48. 10.1590/S0100-879X2009000600007 · DOI
  49. 10.1016/j.jbiotec.2010.06.015 · DOI
  50. 10.1089/ten.tec.2013.0191 · DOI
  51. 10.1038/nbt.1620 · DOI · Paper page
  52. 10.1016/j.scr.2011.04.007 · DOI · Paper page
  53. 10.1038/nbt.1629 · DOI · Paper page
  54. 10.1038/nbt.1631 · DOI · Paper page
  55. 10.1089/ten.tea.2013.0523 · DOI
  56. 10.1016/j.biomaterials.2012.01.060 · DOI
  57. 10.1089/ten.tec.2009.0228 · DOI · Paper page
  58. 10.1002/bit.24375 · DOI
  59. 10.1089/ten.tec.2012.0161 · DOI
  60. 10.1016/j.scr.2012.02.001 · DOI
  61. 10.1038/nprot.2011.318 · DOI · Paper page
  62. 10.1038/nprot.2011.325 · DOI
  63. 10.1016/j.scr.2010.03.005 · DOI · Paper page
  64. 10.1016/j.scr.2010.03.001 · DOI · Paper page
  65. 10.1089/ten.tea.2008.0455 · DOI · Paper page
  66. 10.1186/scrt136 · DOI
  67. 10.1007/s12265-012-9423-2 · DOI
  68. 10.1002/stem.31 · DOI · Paper page
  69. 10.1161/CIRCRESAHA.108.192237 · DOI · Paper page
  70. 10.1007/s12015-010-9189-3 · DOI
  71. 10.3389/fphys.2012.00047 · DOI
  72. 10.1002/stem.1166 · DOI
  73. 10.1146/annurev-bioeng-071910-124715 · DOI
  74. 10.1002/stem.768 · DOI
  75. 10.1371/journal.pone.0018293 · DOI · Paper page
  76. 10.1038/nbt.2249 · DOI · Paper page
  77. 10.1016/j.jcyt.2013.03.006 · DOI
  78. Diekmann U. Lenzen S. Naujok O. A reliable and efficient protocol for human pluripotent stem cell differentiation into the definitive endoderm based on dispersed single cells.Stem Cells Dev.2014 DOI:10.1089/scd.2014.0143. · DOI
  79. 10.1002/stem.1622 · DOI
  80. 10.2217/rme.13.36 · DOI
  81. 10.1089/ten.tec.2010.0104 · DOI
  82. 10.1089/scd.2013.0088 · DOI
  83. 10.1089/ten.tea.2010.0235 · doi:10.1089/ten.tea.2010.0235
  84. 10.1089/ten.tea.2007.0247 · DOI
  85. 10.1016/j.biomaterials.2013.05.079 · DOI
  86. 10.1039/c2ib20040f · DOI
  87. 10.1002/bit.24782 · DOI
  88. 10.1089/ten.tea.2010.0014 · DOI
  89. 10.1038/nature08073 · DOI · Paper page
  90. 10.1089/scd.2011.0225 · DOI
  91. 10.1016/j.ymeth.2008.10.015 · DOI
  92. 10.1016/j.tibtech.2010.03.002 · DOI · Paper page
  93. 10.1016/j.mvr.2011.06.013 · DOI
  94. 10.1371/journal.pone.0052246 · DOI
  95. 10.1002/biot.201300245 · DOI
  96. 10.1002/bit.24717 · DOI
  97. 10.1002/glia.20127 · DOI · Paper page

Cited by

See all 95

Metadata

Authors
Jenkins, M. J., & Farid, S. S.
Venue
Biotechnology Journal
Publisher
Wiley
Published
2014-11-19
Volume
10
Issue
1
Pages
83-95
ISSN
  • 1860-6768
  • 1860-7314
Cited by
95
References
10
Language
en
Funders
Engineering and Physical Sciences Research Council

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human pluripotent stem cell‐derived products: Advances towards robust, scalable and cost‐effective manufacturing strategies. https://app.cochat.ai/papers/10.1002/biot.201400348
The paper
Jenkins, M. J., & Farid, S. S. (2015). Human pluripotent stem cell‐derived products: Advances towards robust, scalable and cost‐effective manufacturing strategies. Biotechnology Journal. https://doi.org/10.1002/biot.201400348

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.